[Federal Register Volume 65, Number 50 (Tuesday, March 14, 2000)]
[Notices]
[Page 13771]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-6120]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 96G-0035]


Sankyo Co., Ltd.; Withdrawal of GRAS Affirmation Petition

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
withdrawal, without prejudice to a future filing, of a petition (GRASP 
6G0420) proposing to affirm that the use of dextranase enzyme 
preparation derived from Chaetomium gracile is generally recognized as 
safe (GRAS) in cane and beet sugar processing.

FOR FURTHER INFORMATION CONTACT: Martha D. Peiperl, Center for Food 
Safety and Applied Nutrition (HFS-215), Food and Drug Administration, 
200 C St. SW.,Washington, DC 20204, 202-418-3077.

SUPPLEMENTARY INFORMATION: In a notice published in the Federal 
Register of February 14, 1996 (61 FR 5787), FDA announced that a 
petition (GRASP 6G0420) had been filed by Solvay Enzymes, Inc., c/o 
1001 G St. NW., suite 500 West, Washington, DC 20001 (now, Sankyo Co., 
Ltd., No. 7-12, Ginza 2-chome, Chuo-ku, Tokyo 104-8113, Japan). This 
petition proposed that the use of dextranase enzyme preparation derived 
from Chaetomium gracile in cane and beet sugar processing be affirmed 
as GRAS. Sankyo has now withdrawn the petition without prejudice to a 
future filing (21 CFR 171.7).

    Dated: March 1, 2000.
Alan M. Rulis,
Director, Office of Premarket Approval, Center for Food Safety and 
Applied Nutrition.
[FR Doc. 00-6120 Filed 3-13-00; 8:45 am]
BILLING CODE 4160-01-F